Effect of an invasive strategy on outcome in patients ≥75 years of age with non-ST-elevation acute coronary syndrome.
Galasso, Gennaro; De Servi, Stefano; Savonitto, Stefano; Strisciuglio, Teresa; Piccolo, Raffaele; Morici, Nuccia; Murena, Ernesto; Cavallini, Claudio; Petronio, Anna Sonia; Piscione, Federico.
Am J Cardiol
; 115(5): 576-80, 2015 Mar 01.
Artigo em Inglês | MEDLINE | ID: mdl-25595527
Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes.
Early versus delayed invasive intervention in acute coronary syndromes.
Legislative smoking bans for reducing harms from secondhand smoke exposure, smoking prevalence and tobacco consumption.
Dual Antiplatelet Therapy Guided by CYP2C19 Polymorphisms after Implantation of Second-Generation Drug-Eluting Stents for Management of Acute Coronary Syndrome.
Long-term versus short-term dual antiplatelet therapy was similarly associated with a lower risk of death, stroke, or infarction in patients with acute coronary syndrome regardless of underlying kidney disease.
Rational and design of a stepped-wedge cluster randomized trial evaluating quality improvement initiative for reducing cardiovascular events among patients with acute coronary syndromes in resource-constrained hospitals in China.
Risk of acute coronary syndrome after parathyroidectomy in patients with end-stage renal disease: A population-based cohort study in Taiwan.
Physical Activity Frequency on the 10-Year Acute Coronary Syndrome (ACS) Prognosis; The Interaction With Cardiovascular Disease History and Diabetes Mellitus: The GREECS Observational Study.
Adherence to the Mediterranean diet in relation to acute coronary syndrome or stroke nonfatal events: a comparative analysis of a case/case-control study.
Homocysteine-lowering interventions for preventing cardiovascular events.